A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer

Completed · Phase 1

Conditions studied: Advanced Cancer

In brief

The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced cancer.

Key facts

Study ID

NCT00421135

Run by

Alaunos Therapeutics

People needed

30

Starts

2006-02-01

Expected to finish

2007-10-01

Last updated by the study team

2009-09-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Metastatic and /or unresectable disease state after previous standard chemotherapy

Where it is running

• Study site — Santa Monica, California, United States
• Study site — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.